535 related articles for article (PubMed ID: 25401497)
21. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
[TBL] [Abstract][Full Text] [Related]
22. Zinc significantly changes the aggregation pathway and the conformation of aggregates of human prion protein.
Pan K; Yi CW; Chen J; Liang Y
Biochim Biophys Acta; 2015 Aug; 1854(8):907-18. PubMed ID: 25922234
[TBL] [Abstract][Full Text] [Related]
23. Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208.
Klajnert B; Cortijo-Arellano M; Cladera J; Majoral JP; Caminade AM; Bryszewska M
Biochem Biophys Res Commun; 2007 Dec; 364(1):20-5. PubMed ID: 17927954
[TBL] [Abstract][Full Text] [Related]
24. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
25. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
Baskakov IV; Bocharova OV
Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
[TBL] [Abstract][Full Text] [Related]
26. Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.
Rouget R; Sharma G; LeBlanc AC
J Biol Chem; 2015 Feb; 290(9):5759-71. PubMed ID: 25572400
[TBL] [Abstract][Full Text] [Related]
27. Distinct morphological and electrophysiological properties of an elk prion peptide.
Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
[TBL] [Abstract][Full Text] [Related]
28. Glucagon fibril polymorphism reflects differences in protofilament backbone structure.
Andersen CB; Hicks MR; Vetri V; Vandahl B; Rahbek-Nielsen H; Thøgersen H; Thøgersen IB; Enghild JJ; Serpell LC; Rischel C; Otzen DE
J Mol Biol; 2010 Apr; 397(4):932-46. PubMed ID: 20156459
[TBL] [Abstract][Full Text] [Related]
29. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
30. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
Yamaguchi K; Matsumoto T; Kuwata K
Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
[TBL] [Abstract][Full Text] [Related]
31. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
Baskakov IV
J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
[TBL] [Abstract][Full Text] [Related]
32. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
Jones EM; Surewicz WK
Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
[TBL] [Abstract][Full Text] [Related]
33. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
Tycko R; Wickner RB
Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
[TBL] [Abstract][Full Text] [Related]
34. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
Nyström S; Hammarström P
Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
[TBL] [Abstract][Full Text] [Related]
35. [A redox process of ethanethiol group increases formation of beta-sheet structure and amyloid fibrils of wild type human prion protein].
Sun H; Shi Q; Wang SB; Guo F; Xie WL; Chen C; Liu CQ; Dong XP
Bing Du Xue Bao; 2012 Jun; 28(4):409-13. PubMed ID: 22978166
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of prion protein assembly into amyloid.
Stöhr J; Weinmann N; Wille H; Kaimann T; Nagel-Steger L; Birkmann E; Panza G; Prusiner SB; Eigen M; Riesner D
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2409-14. PubMed ID: 18268326
[TBL] [Abstract][Full Text] [Related]
38. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
[TBL] [Abstract][Full Text] [Related]
39. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
40. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
